Skip to main content

Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)

  • Sponsored by Sanofi
Mar 09, 2023 11:54 am